(VIANEWS) – Rio Tinto (RIO), Babson Capital Global Short Duration High Yield Fund (BGH), Healthcare Realty Trust Incorporated (HR) have the highest dividend yield stocks on this list.

Rank Financial Asset Price Change Forward Dividend Yield Updated (EST)
1 Rio Tinto (RIO) 74.85 2.63% 10.81% 2022-03-11 09:11:52
2 Babson Capital Global Short Duration High Yield Fund (BGH) 15.53 0.58% 8.18% 2022-03-10 09:11:06
3 Healthcare Realty Trust Incorporated (HR) 30.89 0.13% 4.02% 2022-02-23 05:13:05
4 Novartis AG (NVS) 82.97 1% 3.47% 2022-03-11 09:02:54

Close to 2K companies listed in the Nasdaq and NYSE pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. Rio Tinto (RIO) – Dividend Yield: 10.81%

Rio Tinto Group engages in finding, mining, and processing mineral resources worldwide. The company offers aluminum, silver, molybdenum, copper, diamonds, gold, borates, titanium dioxide, salt, iron ore, and uranium. It is also involved in the alumina production; primary aluminum smelting; bauxite mining; alumina refining; and ilmenite, rutile, and zircon mining, as well as provision of gypsum. Rio Tinto Group was founded in 1873 and is headquartered in London, the United Kingdom.

Volume

Today’s last reported volume for Rio Tinto is 6700500, 44.58% above its average volume of 4634410.

Rio Tinto’s last close was $74.85, 22.01% below its 52-week high of $95.97.

Rio Tinto’s Revenue

Year-on-year quarterly revenue growth grew by 70.9%, now sitting on 58.33B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Rio Tinto’s stock is considered to be overbought (>=80).

Rio Tinto’s Stock Yearly Top and Bottom Value

Rio Tinto’s stock is valued at $74.85 at 09:15 EST, way under its 52-week high of $95.97 and way higher than its 52-week low of $59.58.

Rio Tinto’s Moving Average

Rio Tinto’s value is way above its 50-day moving average of $64.48 and under its 200-day moving average of $77.41.

More news about Rio Tinto.

2. Babson Capital Global Short Duration High Yield Fund (BGH) – Dividend Yield: 8.18%

Babson Capital Global Short Duration High Yield Fund is a closed ended fixed income mutual fund launched and managed by Barings LLC. The fund is co-managed by Babson Capital Global Advisors Limited. It invests in fixed income markets across the globe. The fund primarily invests in global high-yield bonds, loans, and other income-producing instruments that are, at the time of purchase, rated below Baa3 by Moody's Investors Service, Inc. or below BBB- by Standard & Poor's Rating Services. It seeks to invest in securities with a weighted average portfolio duration of three years or less. The fund employs bottom-up fundamental analysis to create its portfolio. It benchmarks the performance of its portfolio against the Bank of America/Merrill Lynch Global Non-Financial High Yield Constrained Index. The fund was formerly known as Babson Capital Global Short Duration High Yield Fund. Babson Capital Global Short Duration High Yield Fund was formed on October 25, 2012 and is domiciled in the United States.

Volume

Today’s last reported volume for Babson Capital Global Short Duration High Yield Fund is 25990, 65.54% below its average volume of 75430.

Babson Capital Global Short Duration High Yield Fund’s last close was $15.53, 11.21% under its 52-week high of $17.49.

Babson Capital Global Short Duration High Yield Fund’s Sales

Babson Capital Global Short Duration High Yield Fund’s sales growth is 5.4% for the current quarter and a decline by 3.3% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Babson Capital Global Short Duration High Yield Fund’s stock is considered to be oversold (<=20).

Babson Capital Global Short Duration High Yield Fund’s Stock Yearly Top and Bottom Value

Babson Capital Global Short Duration High Yield Fund’s stock is valued at $15.53 at 09:15 EST, way below its 52-week high of $17.49 and higher than its 52-week low of $15.12.

Babson Capital Global Short Duration High Yield Fund’s Moving Average

Babson Capital Global Short Duration High Yield Fund’s worth is under its 50-day moving average of $16.32 and under its 200-day moving average of $16.81.

More news about Babson Capital Global Short Duration High Yield Fund.

3. Healthcare Realty Trust Incorporated (HR) – Dividend Yield: 4.02%

Healthcare Realty Trust is a real estate investment trust that integrates owning, managing, financing and developing income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2020, the Company owned 210 real estate properties in 24 states totaling 15.5 million square feet and was valued at approximately $5.5 billion. The Company provided leasing and property management services to 12.0 million square feet nationwide.

Volume

Today’s last reported volume for Healthcare Realty Trust Incorporated is 712463, 36.24% below its average volume of 1117380.

Healthcare Realty Trust Incorporated’s last close was $30.89, 8.53% under its 52-week high of $33.77.

The company’s growth estimates for the ongoing quarter and the next is a negative 52.9% and a negative 50%, respectively.

Healthcare Realty Trust Incorporated’s Revenue

Year-on-year quarterly revenue growth grew by 9%, now sitting on 523.17M for the twelve trailing months.

Healthcare Realty Trust Incorporated’s Stock Yearly Top and Bottom Value

Healthcare Realty Trust Incorporated’s stock is valued at $30.89 at 09:15 EST, under its 52-week high of $33.77 and higher than its 52-week low of $28.73.

Healthcare Realty Trust Incorporated’s Moving Average

Healthcare Realty Trust Incorporated’s worth is under its 50-day moving average of $31.13 and under its 200-day moving average of $31.18.

More news about Healthcare Realty Trust Incorporated.

4. Novartis AG (NVS) – Dividend Yield: 3.47%

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. Its Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology and dermatology, respiratory, cardio-metabolic, established, and cardiovascular, renal and metabolism medicine products. The company's Sandoz segment provides active ingredients and finished dosage forms of small molecule pharmaceuticals to third parties across a range of therapeutic areas, as well as finished dosage form anti-infectives. It also provides active pharmaceutical ingredients and intermediates primarily antibiotics; protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services. Novartis AG has collaboration agreements with Pear Therapeutics; Wyss Institute for Biologically Inspired Engineering at Harvard University and the Dana-Farber Cancer Institute; Science 37; Bill & Melinda Gates Foundation; Amgen; University of California, Berkeley; Bristol-Myers Squibb; Drugs for Neglected Diseases initiative (DNDi); TScan Therapeutics; Dyno Therapeutics Inc.; and Olema Oncology. The company was founded in 1895 and is headquartered in Basel, Switzerland.

Volume

Today’s last reported volume for Novartis AG is 2655720, 8.01% below its average volume of 2887120.

Novartis AG’s last close was $82.97, 15.78% below its 52-week high of $98.52.

Novartis AG’s Sales

Novartis AG’s sales growth is 5.7% for the current quarter and 4.5% for the next. The company’s growth estimates for the ongoing quarter and the next is 7.9% and 14.2%, respectively.

Novartis AG’s Revenue

Year-on-year quarterly revenue growth grew by 14.4%, now sitting on 51.56B for the twelve trailing months.

Novartis AG’s Stock Yearly Top and Bottom Value

Novartis AG’s stock is valued at $82.97 at 09:15 EST, way under its 52-week high of $98.52 and higher than its 52-week low of $81.01.

Novartis AG’s Moving Average

Novartis AG’s value is below its 50-day moving average of $83.05 and below its 200-day moving average of $88.43.

More news about Novartis AG.

LEAVE A REPLY

Please enter your comment!
Please enter your name here